Rosemount Company Profile
What is the competitive landscape for ROSEMOUNT
ROSEMOUNT has four approved drugs.
There are nine US patents protecting ROSEMOUNT drugs.
Summary for Rosemount
| US Patents: | 9 |
| Tradenames: | 5 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Rosemount
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rosemount | NEXICLON XR | clonidine | TABLET, EXTENDED RELEASE;ORAL | 022500-001 | Dec 3, 2009 | RX | No | No | 8,337,890 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Rosemount | OZOBAX DS | baclofen | SOLUTION;ORAL | 208193-002 | Oct 12, 2023 | AA | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rosemount | NEXICLON XR | clonidine | TABLET, EXTENDED RELEASE;ORAL | 022500-001 | Dec 3, 2009 | RX | No | No | 8,623,409 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Rosemount | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-002 | Aug 14, 2009 | DISCN | Yes | No | 7,741,374 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rosemount | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-002 | Aug 14, 2009 | DISCN | Yes | No | 7,915,247 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Rosemount Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 101495146 | ⤷ Start Trial |
| Denmark | 2018160 | ⤷ Start Trial |
| Japan | 2009530298 | ⤷ Start Trial |
| Brazil | PI0709606 | ⤷ Start Trial |
| European Patent Office | 2018160 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Rosemount Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0566709 | C300152 | Netherlands | ⤷ Start Trial | PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405 |
| 2488169 | C202330042 | Spain | ⤷ Start Trial | PRODUCT NAME: COCRISTAL DE TRAMADOL, OPCIONALMENTE EN FORMA DE UNA SAL FISIOLOGICAMENTE ACEPTABLE, Y CELECOXIB; NATIONAL AUTHORISATION NUMBER: 89051; DATE OF AUTHORISATION: 20230925; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 89051; DATE OF FIRST AUTHORISATION IN EEA: 20230925 |
| 0566709 | SPC/GB04/012 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
